Commentary on systematic review, economic, and financial analysis submitted to Pharmaceutical Benefits Advisory committee (PBAC) #5 of 6 in 2020

Martin Hoyle

Commentary on systematic review, economic, and financial analysis submitted to Pharmaceutical Benefits Advisory committee (PBAC) #5 of 6 in 2020

Research output: Book/Report › Commissioned report

Original language	English
Publisher	Australian Government Department of Health
Commissioning body	Department of Health, Disability and Ageing (Commonwealth)
Publication status	Published - 1 Jan 2020

Cite this

@book{7af36f4ad9804521876414a29b870051,

title = "Commentary on systematic review, economic, and financial analysis submitted to Pharmaceutical Benefits Advisory committee (PBAC) \#5 of 6 in 2020",

author = "Martin Hoyle",

year = "2020",

month = jan,

day = "1",

language = "English",

publisher = "Australian Government Department of Health",

}

TY - BOOK

T1 - Commentary on systematic review, economic, and financial analysis submitted to Pharmaceutical Benefits Advisory committee (PBAC) #5 of 6 in 2020

AU - Hoyle, Martin

PY - 2020/1/1

Y1 - 2020/1/1

M3 - Commissioned report

BT - Commentary on systematic review, economic, and financial analysis submitted to Pharmaceutical Benefits Advisory committee (PBAC) #5 of 6 in 2020

PB - Australian Government Department of Health

ER -